Global Nuclear Medicine & Radiopharmaceuticals Market Research Report 2023

Publisher Name :
Date: 07-Jan-2023
No. of pages: 91
Inquire Before Buying

Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

Highlights

The global Nuclear Medicine & Radiopharmaceuticals market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine & Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine & Radiopharmaceuticals.

The Nuclear Medicine & Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nuclear Medicine & Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nuclear Medicine & Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- China Isotope & Radiation

- Dongcheng

- Jaco

- Ciaeriar

- Advanced Molecular-imaging Solution

- Shanghai Atom Kexing

Segment by Type

- Diagnostic

- Therapeutic

Segment by Application

- Oncology

- Thyroid

- Cardiology

- Others

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Nuclear Medicine & Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Nuclear Medicine & Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Nuclear Medicine & Radiopharmaceuticals Market Research Report 2023

Table of Contents
1 Scopolamine Market Overview
1.1 Product Overview and Scope of Scopolamine
1.2 Scopolamine Segment by Type
1.2.1 Global Scopolamine Market Value Comparison by Type (2023-2029)
1.2.2 Scopolamine Butylbromide
1.2.3 Scopolamine Hydrobromide
1.2.4 Others
1.3 Scopolamine Segment by Application
1.3.1 Global Scopolamine Market Value by Application: (2023-2029)
1.3.2 Tablets
1.3.3 Injection
1.3.4 Patches
1.4 Global Scopolamine Market Size Estimates and Forecasts
1.4.1 Global Scopolamine Revenue 2018-2029
1.4.2 Global Scopolamine Sales 2018-2029
1.4.3 Global Scopolamine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Scopolamine Market Competition by Manufacturers
2.1 Global Scopolamine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Scopolamine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Scopolamine Average Price by Manufacturers (2018-2023)
2.4 Global Scopolamine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Scopolamine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Scopolamine, Product Type & Application
2.7 Scopolamine Market Competitive Situation and Trends
2.7.1 Scopolamine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Scopolamine Players Market Share by Revenue
2.7.3 Global Scopolamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Scopolamine Retrospective Market Scenario by Region
3.1 Global Scopolamine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Scopolamine Global Scopolamine Sales by Region: 2018-2029
3.2.1 Global Scopolamine Sales by Region: 2018-2023
3.2.2 Global Scopolamine Sales by Region: 2024-2029
3.3 Global Scopolamine Global Scopolamine Revenue by Region: 2018-2029
3.3.1 Global Scopolamine Revenue by Region: 2018-2023
3.3.2 Global Scopolamine Revenue by Region: 2024-2029
3.4 North America Scopolamine Market Facts & Figures by Country
3.4.1 North America Scopolamine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Scopolamine Sales by Country (2018-2029)
3.4.3 North America Scopolamine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Scopolamine Market Facts & Figures by Country
3.5.1 Europe Scopolamine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Scopolamine Sales by Country (2018-2029)
3.5.3 Europe Scopolamine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Scopolamine Market Facts & Figures by Country
3.6.1 Asia Pacific Scopolamine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Scopolamine Sales by Country (2018-2029)
3.6.3 Asia Pacific Scopolamine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Scopolamine Market Facts & Figures by Country
3.7.1 Latin America Scopolamine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Scopolamine Sales by Country (2018-2029)
3.7.3 Latin America Scopolamine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Scopolamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Scopolamine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Scopolamine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Scopolamine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Scopolamine Sales by Type (2018-2029)
4.1.1 Global Scopolamine Sales by Type (2018-2023)
4.1.2 Global Scopolamine Sales by Type (2024-2029)
4.1.3 Global Scopolamine Sales Market Share by Type (2018-2029)
4.2 Global Scopolamine Revenue by Type (2018-2029)
4.2.1 Global Scopolamine Revenue by Type (2018-2023)
4.2.2 Global Scopolamine Revenue by Type (2024-2029)
4.2.3 Global Scopolamine Revenue Market Share by Type (2018-2029)
4.3 Global Scopolamine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Scopolamine Sales by Application (2018-2029)
5.1.1 Global Scopolamine Sales by Application (2018-2023)
5.1.2 Global Scopolamine Sales by Application (2024-2029)
5.1.3 Global Scopolamine Sales Market Share by Application (2018-2029)
5.2 Global Scopolamine Revenue by Application (2018-2029)
5.2.1 Global Scopolamine Revenue by Application (2018-2023)
5.2.2 Global Scopolamine Revenue by Application (2024-2029)
5.2.3 Global Scopolamine Revenue Market Share by Application (2018-2029)
5.3 Global Scopolamine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Alkaloids of Australia
6.1.1 Alkaloids of Australia Corporation Information
6.1.2 Alkaloids of Australia Description and Business Overview
6.1.3 Alkaloids of Australia Scopolamine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Alkaloids of Australia Scopolamine Product Portfolio
6.1.5 Alkaloids of Australia Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Scopolamine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boehringer Ingelheim Scopolamine Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Fine Chemicals Corporation
6.3.1 Fine Chemicals Corporation Corporation Information
6.3.2 Fine Chemicals Corporation Description and Business Overview
6.3.3 Fine Chemicals Corporation Scopolamine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fine Chemicals Corporation Scopolamine Product Portfolio
6.3.5 Fine Chemicals Corporation Recent Developments/Updates
6.4 Phytex Australia
6.4.1 Phytex Australia Corporation Information
6.4.2 Phytex Australia Description and Business Overview
6.4.3 Phytex Australia Scopolamine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Phytex Australia Scopolamine Product Portfolio
6.4.5 Phytex Australia Recent Developments/Updates
6.5 Alchem International
6.5.1 Alchem International Corporation Information
6.5.2 Alchem International Description and Business Overview
6.5.3 Alchem International Scopolamine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Alchem International Scopolamine Product Portfolio
6.5.5 Alchem International Recent Developments/Updates
6.6 Guangzhou Hanfang
6.6.1 Guangzhou Hanfang Corporation Information
6.6.2 Guangzhou Hanfang Description and Business Overview
6.6.3 Guangzhou Hanfang Scopolamine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Guangzhou Hanfang Scopolamine Product Portfolio
6.6.5 Guangzhou Hanfang Recent Developments/Updates
6.7 Alkaloids Corporation
6.6.1 Alkaloids Corporation Corporation Information
6.6.2 Alkaloids Corporation Description and Business Overview
6.6.3 Alkaloids Corporation Scopolamine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Alkaloids Corporation Scopolamine Product Portfolio
6.7.5 Alkaloids Corporation Recent Developments/Updates
6.8 Luyin
6.8.1 Luyin Corporation Information
6.8.2 Luyin Description and Business Overview
6.8.3 Luyin Scopolamine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Luyin Scopolamine Product Portfolio
6.8.5 Luyin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Scopolamine Industry Chain Analysis
7.2 Scopolamine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Scopolamine Production Mode & Process
7.4 Scopolamine Sales and Marketing
7.4.1 Scopolamine Sales Channels
7.4.2 Scopolamine Distributors
7.5 Scopolamine Customers
8 Scopolamine Market Dynamics
8.1 Scopolamine Industry Trends
8.2 Scopolamine Market Drivers
8.3 Scopolamine Market Challenges
8.4 Scopolamine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Nuclear Medicine & Radiopharmaceuticals Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Nuclear Medicine & Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Nuclear Medicine & Radiopharmaceuticals, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Product Type & Application
Table 12. Global Key Manufacturers of Nuclear Medicine & Radiopharmaceuticals, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nuclear Medicine & Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2018-2023) & (K Units)
Table 18. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2018-2023)
Table 19. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2024-2029) & (K Units)
Table 20. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2024-2029)
Table 21. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2018-2023)
Table 23. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2024-2029)
Table 25. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 27. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)
Table 28. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 32. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)
Table 33. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2018-2023)
Table 51. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Type (2024-2029)
Table 52. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2018-2023)
Table 53. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2024-2029)
Table 54. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2018-2023)
Table 57. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2024-2029)
Table 58. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Type (2018-2023)
Table 59. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Type (2024-2029)
Table 60. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2018-2023)
Table 61. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Units) by Application (2024-2029)
Table 62. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Table 63. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2024-2029)
Table 64. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Nuclear Medicine & Radiopharmaceuticals Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2018-2023)
Table 67. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2024-2029)
Table 68. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Application (2018-2023)
Table 69. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Application (2024-2029)
Table 70. China Isotope & Radiation Corporation Information
Table 71. China Isotope & Radiation Description and Business Overview
Table 72. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product
Table 74. China Isotope & Radiation Recent Developments/Updates
Table 75. Dongcheng Corporation Information
Table 76. Dongcheng Description and Business Overview
Table 77. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product
Table 79. Dongcheng Recent Developments/Updates
Table 80. Jaco Corporation Information
Table 81. Jaco Description and Business Overview
Table 82. Jaco Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Jaco Nuclear Medicine & Radiopharmaceuticals Product
Table 84. Jaco Recent Developments/Updates
Table 85. Ciaeriar Corporation Information
Table 86. Ciaeriar Description and Business Overview
Table 87. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product
Table 89. Ciaeriar Recent Developments/Updates
Table 90. Advanced Molecular-imaging Solution Corporation Information
Table 91. Advanced Molecular-imaging Solution Description and Business Overview
Table 92. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product
Table 94. Advanced Molecular-imaging Solution Recent Developments/Updates
Table 95. Shanghai Atom Kexing Corporation Information
Table 96. Shanghai Atom Kexing Description and Business Overview
Table 97. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product
Table 99. Shanghai Atom Kexing Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Nuclear Medicine & Radiopharmaceuticals Distributors List
Table 103. Nuclear Medicine & Radiopharmaceuticals Customers List
Table 104. Nuclear Medicine & Radiopharmaceuticals Market Trends
Table 105. Nuclear Medicine & Radiopharmaceuticals Market Drivers
Table 106. Nuclear Medicine & Radiopharmaceuticals Market Challenges
Table 107. Nuclear Medicine & Radiopharmaceuticals Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nuclear Medicine & Radiopharmaceuticals
Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Nuclear Medicine & Radiopharmaceuticals Market Share by Type in 2022 & 2029
Figure 4. Diagnostic Product Picture
Figure 5. Therapeutic Product Picture
Figure 6. Global Nuclear Medicine & Radiopharmaceuticals Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Nuclear Medicine & Radiopharmaceuticals Market Share by Application in 2022 & 2029
Figure 8. Oncology
Figure 9. Thyroid
Figure 10. Cardiology
Figure 11. Others
Figure 12. Global Nuclear Medicine & Radiopharmaceuticals Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)
Figure 14. Global Nuclear Medicine & Radiopharmaceuticals Sales (2018-2029) & (K Units)
Figure 15. Global Nuclear Medicine & Radiopharmaceuticals Average Price (USD/Unit) & (2018-2029)
Figure 16. Nuclear Medicine & Radiopharmaceuticals Report Years Considered
Figure 17. Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturers in 2022
Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Nuclear Medicine & Radiopharmaceuticals Players: Market Share by Revenue in 2022
Figure 20. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2018-2029)
Figure 23. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2018-2029)
Figure 27. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2018-2029)
Figure 28. Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2018-2029)
Figure 35. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2018-2029)
Figure 45. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Nuclear Medicine & Radiopharmaceuticals by Type (2018-2029)
Figure 55. Global Revenue Market Share of Nuclear Medicine & Radiopharmaceuticals by Type (2018-2029)
Figure 56. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Nuclear Medicine & Radiopharmaceuticals by Application (2018-2029)
Figure 58. Global Revenue Market Share of Nuclear Medicine & Radiopharmaceuticals by Application (2018-2029)
Figure 59. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Unit) by Application (2018-2029)
Figure 60. Nuclear Medicine & Radiopharmaceuticals Value Chain
Figure 61. Nuclear Medicine & Radiopharmaceuticals Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs